BIOTRONIK Asia-Pacific Hub Hits Three Million Cardiac Leads Manufactured in Singapore Milestone Underscores Singapore’s Growing Role in High‑Precision MedTech Manufacturing
BIOTRONIK, a global leader in medical technology, is marking a significant achievement at its Asia-Pacific Hub (BIOHUB) in Singapore with the production of three million cardiac rhythm management (CRM) leads. Since beginning operations in late 2017, BIOTRONIK has experienced significant growth in Singapore.
Each lead manufactured in Singapore represents a critical component in cardiac rhythm therapy systems including devices such as pacemakers and implantable cardioverter defibrillators (ICDs). These leads support patients who require precise, reliable electrical signaling to maintain healthy heart rhythms and carry out their daily activities. This latest milestone underscores both the capacity and the consistent quality of BIOTRONIK’s production processes, as well as the company’s mission to enable better patient outcomes globally.
“This achievement demonstrates the growing importance of Singapore in improving global access to advanced cardiac care,” said Peter Horan, Managing Director, Asia Pacific Manufacturing. “Every lead produced here supports a patient who depends on precise and reliable therapy. I’m very proud of the team here for their expertise, dedication, and deep commitment to delivering the highest-quality medical technology to patients around the world.”
In December 2023, BIOTRONIK opened its new Asia-Pacific Manufacturing and Research Hub. This 20,000 m² facility integrates manufacturing, quality, and research & development under one roof. The hub employs hundreds of specialists across these areas, featuring modern cleanrooms and laboratories that are dedicated to developing advanced CRM devices. The BIOHUB represents BIOTRONIK’s long‑term commitment to strengthening Singapore’s MedTech ecosystem.
Catch journalist and marathon runner Marianella Cordero talk about her pacemaker.
– END –
About BIOTRONIK
For over 60 years, BIOTRONIK has stood at the forefront of medical technology, pioneering breakthrough innovations that are transforming the lives of millions affected by heart disease and chronic pain. Rooted in a deep purpose to seamlessly harmonize technology with the human body, we engineer trusted, life-changing therapies through our advanced active implants in Cardiac Rhythm Management, Monitoring, and Neuromodulation, while providing cutting-edge solutions in Electrophysiology. From creating Germany’s first pacemaker in 1963 to breaking new ground in digital technologies and Conduction System Pacing today, BIOTRONIK is continuously raising the bar for quality, performance, and innovation. Headquartered in Berlin, our global reach spans over 100 countries across the Americas, EMEA, and Asia—bringing bold, future-ready solutions that are shaping the next generation of medical technology.
